Celcuity (CELC) Short-term Investments (2017 - 2025)
Celcuity (CELC) reported Short-term Investments of $275.8 million for Q4 2025, up 29.73% on a YoY basis from $212.6 million in Q4 2024, and down 27.56% quarter-over-quarter from $380.7 million in Q3 2025.
Celcuity (CELC) Short-term Investments (2017 - 2025) Analysis & Trends
Celcuity has reported Short-term Investments for 9 years, with the latest figure at $275.8 million in Q4 2025.
- For the quarter ending Q4 2025, Short-term Investments rose 29.73% year-over-year to $275.8 million; the trailing twelve-month figure through Dec 2025 stood at $275.8 million (up 29.73% YoY), and the FY2025 full-year result was $275.8 million, up 29.73% from the prior year.
- Short-term Investments for Q4 2025 stood at $275.8 million, down from $380.7 million in the prior quarter.
- The five-year high for Short-term Investments was $380.7 million in Q3 2025, with the low at $22009.0 in Q1 2021.
- Historically, Short-term Investments has averaged $111.7 million across 5 years, with a median of $115.1 million in 2023.
- Annual changes were most pronounced in 2024 — Short-term Investments jumped 1147656.02% — and 2025, when it plunged 51.69%.
- Celcuity's Short-term Investments stood at $22009.0 in 2021, then soared by 654250.28% to $144.0 million in 2022, then increased by 4.1% to $149.9 million in 2023, then soared by 41.8% to $212.6 million in 2024, then advanced by 29.73% to $275.8 million in 2025.
- The last three Short-term Investments figures came in at $275.8 million (Q4 2025), $380.7 million (Q3 2025), and $122.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 275.79 Mn |
| Sep 30, 2025 | 380.73 Mn |
| Jun 30, 2025 | 122.03 Mn |
| Mar 31, 2025 | 189.21 Mn |
| Dec 31, 2024 | 212.59 Mn |
| Sep 30, 2024 | 251.46 Mn |
| Jun 30, 2024 | 252.61 Mn |
| Mar 31, 2024 | 146.45 Mn |
| Dec 31, 2023 | 149.92 Mn |
| Sep 30, 2023 | 108.18 Mn |
| Jun 30, 2023 | 22,009.00 |
| Mar 31, 2023 | 22,009.00 |
| Dec 31, 2022 | 144.02 Mn |
| Sep 30, 2022 | 22,009.00 |
| Jun 30, 2022 | 22,009.00 |
| Mar 31, 2022 | 22,009.00 |
| Dec 31, 2021 | 22,009.00 |
| Sep 30, 2021 | 22,009.00 |
| Jun 30, 2021 | 22,009.00 |
| Mar 31, 2021 | 22,009.00 |